Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on ...
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from a sex-specific analysis of 160 real-world ...
A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...
Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Peter Monteleone will present data from a sex-specific ...
HealthDay on MSN
American Academy of Ophthalmology, Oct. 18-20
The annual meeting of the American Academy of Ophthalmology was held from Oct. 18 to 20 in Orlando, Florida, and attracted ...
Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...
According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...
Thank you, Sabrina, and good morning, everyone. The third quarter was another exceptional quarter for GeneDx. Achieving that vision requires a fast-growing, disciplined, profitable business that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback